SDC1 and esophageal cancer: Several studies immunohistochemically investigated the prognostic influence of CD20 + , CD38 + , and CD138 + TILs on esophageal cancer, gastric cancer, colorectal cancer, melanoma, ovarian cancer, and non-small cell lung cancer [1–6].